|
|
|
Insider
Information: |
Cohen Raymond W |
Relationship: |
|
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
284,273 |
|
Indirect Shares
|
692,151 |
|
|
Direct
Value |
$13,420,945 |
|
|
Indirect Value
|
$46,754,800 |
|
|
Total
Shares |
976,424 |
|
|
Total
Value |
$60,175,745 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
8
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
88.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cardiac Science Corp |
CSCX |
Director |
2009-05-22 |
13,825 |
|
0 |
Premium* |
|
Spectrum Pharmaceuticals Inc |
SPPI |
Director |
2019-06-20 |
53,850 |
2013-12-13 |
0 |
Premium* |
|
Biolife Solutions Inc |
BLFS |
Director |
2021-07-12 |
27,763 |
2014-05-20 |
0 |
Premium* |
|
Axonics Modulation Technologies,... |
AXNX |
|
2024-01-31 |
188,835 |
2019-08-06 |
692,151 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2018-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
8,760 |
688,651 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2019-08-06 |
4 |
B |
$30.41 |
$106,439 |
D/D |
3,500 |
683,391 |
0.01 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2019-11-19 |
4 |
S |
$20.74 |
$1,555,125 |
D/D |
(75,000) |
608,391 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-01-13 |
4 |
AS |
$31.98 |
$319,800 |
D/D |
(10,000) |
608,391 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-01-13 |
4 |
OE |
$1.63 |
$16,300 |
D/D |
10,000 |
618,391 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
625,058 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-02-13 |
4 |
AS |
$33.21 |
$332,065 |
D/D |
(10,000) |
542,058 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-02-13 |
4 |
OE |
$1.63 |
$16,300 |
D/D |
10,000 |
552,058 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-03-16 |
4 |
AS |
$20.87 |
$864,639 |
D/D |
(41,224) |
542,058 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-03-16 |
4 |
OE |
$1.63 |
$67,195 |
D/D |
41,224 |
583,282 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-07-13 |
4 |
AS |
$40.34 |
$1,008,761 |
D/D |
(25,000) |
517,058 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-07-14 |
4 |
AS |
$36.49 |
$912,273 |
D/D |
(25,000) |
492,058 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-07-15 |
4 |
AS |
$38.55 |
$981,327 |
D/D |
(25,000) |
467,058 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-07-16 |
4 |
AS |
$39.65 |
$991,268 |
D/D |
(25,000) |
442,058 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-08-07 |
4 |
AS |
$41.82 |
$839,583 |
D/D |
(20,000) |
422,058 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-08-11 |
4 |
AS |
$40.95 |
$1,053,636 |
D/D |
(25,000) |
397,058 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,173 |
424,231 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-01-26 |
4 |
S |
$53.58 |
$420,148 |
D/D |
(7,842) |
416,389 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
436,389 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-02-01 |
4 |
S |
$51.36 |
$700,661 |
D/D |
(13,627) |
456,096 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,334 |
469,723 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-05-10 |
4 |
AS |
$52.98 |
$1,818,158 |
D/D |
(33,833) |
350,773 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-05-18 |
4 |
AS |
$55.00 |
$1,805,815 |
D/D |
(32,833) |
317,940 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-06-08 |
4 |
AS |
$60.00 |
$1,999,980 |
D/D |
(33,333) |
284,607 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-09-09 |
4 |
AS |
$77.11 |
$3,855,350 |
D/D |
(50,000) |
234,607 |
0 |
% |
|
81 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|